Brent Xia
Surgical Oncology · Edgewood, KYNPI 1306289871
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,406 of the $3,095 with a category attached, or 77.7%. 15 manufacturers reported payments, led by Histosonics, Inc. at 37.9% of the total. 2025 is the largest year on record at $2,298, more than ten times the $97 reported in 2021.
Across 21 payments — averaging $147.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Histosonics, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$334
- Medtronic$281
- Siemens Medical Solutions USA, Inc.$150
- Incyte Corporation$132
- AstraZeneca$126
- plus $900 from 9 others
What the payments were for
- Travel & lodging$68922%
- Food & beverage$2,40678%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Histosonics, Inc. | 2 | $1,173 |
| E.r. Squibb & Sons, L.L.C. | 3 | $334 |
| Medtronic | 2 | $281 |
| Siemens Medical Solutions USA, Inc. | 1 | $150 |
| Incyte Corporation | 1 | $132 |
| AstraZeneca | 1 | $126 |
| Boston Scientific | 2 | $125 |
| Alcresta Therapeutics, Inc. | 1 | $124 |
| Solventum Corporation | 1 | $123 |
| Davol Inc. | 1 | $115 |
| Ipsen Biopharmaceuticals, Inc | 1 | $110 |
| AbbVie | 1 | $97 |
| Intera Oncology, Inc | 1 | $82 |
| Advanced Critical Devices, Inc. | 1 | $77 |
| Medical Device Business Services, Inc. | 2 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$281
- OPDIVO$247
- MicroThermX Microwave Ablation System$150
- ZYNYZ$132
- RELIZORB$124
- V.A.C. VERAFLO$123
- Phasix Mesh$115
- ONIVYDE$110
- TheraSphere Y90 Glass Microspheres 10 GBq$110
How this compares
$3,095 in reported general payments places this provider in the 55th percentile of 29 surgical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 42 | $84,133 |
| Enoxaparin Sodium | 22 | $1,496 |
| Pantoprazole Sodium | 55 | $623 |
| Oxycodone Hcl | 34 | $191 |
| Tramadol Hcl | 30 | $62 |
| Metoprolol Tartrate | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $97 | $84,13342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 29 surgical oncology providers in Kentucky.
Other surgical oncology in Edgewood
- Joseph GuentherEdgewood$5K
- Kelly MackessyEdgewood$243
- Robert MartinLouisville$483K
- Jennifer WhittingtonLexington$22K
- Charles ScogginsLouisville$15K
- Nicolas AjkayLouisville$11K
- Prejesh PhilipsLouisville$9K
- Prakash PandalaiLexington$8K
- Daniel KenadyHazard$6K
- Mary HughesAshland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.